Login Register
Follow Us

AstraZeneca Pharma India to launch cancer drug

Acalabrutinib 100 mg capsules are used for treatment of various types of blood cancers

Show comments

New Delhi, October 15

Drug firm AstraZeneca Pharma India on Thursday said it would launch its Acalabrutinib 100 mg capsules, used for treatment of various types of blood cancers, under the brand name 'Calquence' in the country on October 21.

The capsules are indicated for treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy and for treatment of patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), AstraZeneca Pharma India said in a filing to the BSE.

Shares of AstraZeneca Pharma India Ltd on Thursday closed 0.61 per cent lower at Rs 4,266.65 apiece on the BSE. PTI

Show comments
Show comments

Trending News

Also In This Section


Top News


View All

Scottish Sikh artist Jasleen Kaur shortlisted for prestigious Turner Prize

Jasleen Kaur, in her 30s, has been nominated for her solo exhibition entitled ‘Alter Altar' at Tramway contemporary arts venue in Glasgow

Amritsar: ‘Jallianwala Bagh toll 57 more than recorded’

GNDU team updates 1919 massacre toll to 434 after two-year study

Meet Gopi Thotakura, a pilot set to become 1st Indian to venture into space as tourist

Thotakura was selected as one of the six crew members for the mission, the flight date of which is yet to be announced


Most Read In 24 Hours

8

Punjab The Tribune interview

PM to accord farmers red carpet welcome after poll